SOURCE: Edwards Lifesciences

Edwards Lifesciences

January 11, 2010 09:00 ET

Edwards Lifesciences' Critical Care Technologies to Be Available via Philips Monitors

IRVINE, CA--(Marketwire - January 11, 2010) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that in an effort to make its clinically validated critical care parameters more widely accessible through licensing, it has signed its first agreement with Philips Healthcare to enable the integration of its oximetry technology with the Philips IntelliVue patient monitors.

"This new agreement is designed to enable clinicians to conveniently obtain the valuable parameters provided by our sensors and catheters through a variety of monitors," said Carlyn D. Solomon, corporate vice president, critical care. "In this way, we intend to improve clinical work flow by reducing the number of monitors required per patient, and enabling easier integration with electronic medical records."

Through this collaboration, a module has been developed to facilitate compatibility of Edwards' advanced monitoring technology with the industry's leading range of patient monitors. Edwards' full-line of oximetry catheters, including PreSep, PediaSat and Swan-Ganz, will be used with the Philips IntelliVue MP40 through MP90 patient monitors.

"As a result of integrating leading-edge measurement technologies into its range of patient monitors, Philips continues to contribute towards the reduction of equipment clutter around the patient's bedside," said David A. Russell, vice president of marketing for Philips Healthcare Informatics and Patient Monitoring.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company's global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

Contact Information

  • Media Contact:
    Amanda C. Fowler
    949-250-5070

    Investor Contact:
    David K. Erickson
    949-250-6826